The authors particularly Notice The shortage of randomized controlled trials for orthopaedic indications—that means we will’t confidently say it works, what the true side-impact profile is, or what a “safe dose” will be in the true planet (systematic overview, 2024).In case the intention is “considerably less downtime, extra instruction,�